Omeros (OMER) Other Operating Expenses (2012 - 2026)

Omeros' (OMER) quarterly Other Operating Expenses came in at $587000.0 in Q1 2026, down 97.8% quarter-over-quarter from $26.7 million in Q4 2020.

Omeros (OMER) Other Operating Expenses (2012 - 2026) Analysis & Trends

Omeros has disclosed Other Operating Expenses across 9 years of filings, most recently posting $587000.0 for Q1 2026.

Other Operating Expenses for Q1 2026 came in at $587000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $587000.0 (changed N/A YoY), and the FY2025 annual result was $237.6 million, changed N/A from the prior year.
Other Operating Expenses came in at $587000.0 for Q1 2026 at Omeros, down from $26.7 million in the prior quarter.
In the past five years, Other Operating Expenses ranged from a high of $587000.0 in Q1 2026 to a low of $587000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Omeros	737.87 Mn	602.55 Mn	9.31 Mn

Download Data